HomeDiureticsDiuretics + Empagliflozin And Linagliptin

Does Diuretics Interact with Empagliflozin And Linagliptin?

Diuretics and Empagliflozin And Linagliptin have a moderate drug interaction according to U.S. FDA drug labeling data. Coadministration with empagliflozin increases urine volume and frequency, enhancing potential for volume depletion. Monitor volume status and renal function. The mechanism involves increased urine volume and frequency of voids. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Empagliflozin And Linagliptin Class
Dipeptidyl Peptidase 4 Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Diuretics and Empagliflozin And Linagliptin occurs because increased urine volume and frequency of voids. Clinically, this means coadministration with empagliflozin increases urine volume and frequency, enhancing potential for volume depletion. monitor volume status and renal function. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Diuretics and your doctor is considering prescribing Empagliflozin And Linagliptin (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Diuretics(Diabetic Tussin EX)+💊 Empagliflozin And Linagliptin(Glyxambi)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Dipeptidyl Peptidase 4 Inhibitor
Source
NLP:empagliflozin and linagliptin

What this means in plain English

Coadministration with empagliflozin increases urine volume and frequency, enhancing potential for volume depletion. Monitor volume status and renal function.

About Diuretics and Empagliflozin And Linagliptin

Empagliflozin And Linagliptin is a Dipeptidyl Peptidase 4 Inhibitor. Empagliflozin And Linagliptin is also sold under the brand name Glyxambi. Empagliflozin And Linagliptin is taken by mouth.

What the FDA label says

"Increased urine volume and frequency of voids"

📖 Source: NLP:empagliflozin and linagliptin

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Diuretics and Empagliflozin And Linagliptin against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.